Adenylation Enzyme Inhibitors
AssigneeStichting Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
InventorsHuib Ovaa, Farid El Oualid, Monique Mulder
Life of this patent
Estimating the term…
Loading patent…
AssigneeStichting Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
InventorsHuib Ovaa, Farid El Oualid, Monique Mulder
Estimating the term…
The present invention concerns compounds that are capable of covalently entrapping adenylating enzymes. The present invention is essentially based on the discovery that analogues of adenylating enzyme (AE) substrates, wherein a methylene group has been incorporated at the carbon atom in the α-position relative to the carboxylate group involved in the adenylation, are capable of undergoing the adenylation reaction, thereby creating an activated methylene group in situ. The resulting ‘armed’ acyladenylate can interact with the enzyme resulting in covalent entrapment. Interestingly, the acyladenylate can alternatively be transferred to the next step in the enzyme cascade, following which the activated methylene group can interact with the next (active site cysteine containing) enzyme in the enzymatic cascade. The AE substrate analogues, based on their capability of ‘entrapping’ the respective enzymes, will have utility as activity based probes in biological research and also as diagnostic and/or therapeutic agents.
Adenylating enzyme (AE) substrate analogues having the structure:
An adenylating enzyme (AE) substrate analogue having the structure according to formula (I):
A method for producing an adenylating enzyme (AE) substrate analogue comprising the steps of:
Dependencies are inferred from the claim text.